• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight
          Entry Author Date Location
          Dewpoint Therapeutics Taps Ex-Sanofi Executive Ameet Nathwani as CEO Frank Vinluan 10/13/20 Boston
          Invetx Appoints Bill Brondyk, Colin Giles to Executive Team Frank Vinluan 09/30/20 Boston
          Thrive Earlier Detection Taps CVS’s Asgarian as Chief Medical Officer Frank Vinluan 09/30/20 Boston
          Ex-Radius Health Exec Carmona Joins Rubius as Chief Financial Officer Frank Vinluan 09/28/20 Boston
          Freeline Therapeutics Promotes Corbau to Chief Scientific Officer Frank Vinluan 09/28/20 Europe
          Silence Therapeutics Taps Orchard’s Mark Rothera as President & CEO Frank Vinluan 09/14/20 Europe
          Synlogic Names Metera’s David Hava as Chief Scientific Officer Frank Vinluan 09/14/20 Boston
          Agios Exec Andrew Hirsch Jumps to C4 Therapeutics for CEO Role Frank Vinluan 09/08/20 Boston
          AlloVir Taps Merck’s Atillasoy as Chief Regulatory & Safety Officer Frank Vinluan 09/08/20 Boston
          Kura Oncology Adds Kyowa Kirin’s Stephen Dale as Chief Medical Officer Sarah de Crescenzo 08/25/20 San Diego
          Page 1 of 102 next page »

          Underwriters and Partners

          Xconomy Insight
          • How to Approach Life Sciences Fundraising

            Sponsored · Whitepaper

            How to Approach Life Sciences Fundraising

            Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research

            Brex
          • CMC in Drug Development and Life Cycle Management

            Sponsored · Whitepaper

            CMC in Drug Development and Life Cycle Management

            CMC in Drug Development and Life Cycle Management

            PRA Health Sciences
          • How Healthy Are Your Market Access Programs?

            Sponsored · Whitepaper

            How Healthy Are Your Market Access Programs?

            A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs

            Archbow Consulting

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2023, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.